300529 健帆生物
已收盘 12-20 15:00:00
资讯
新帖
简况
健帆生物12月18日现1笔大宗交易 成交金额207.93万元
新浪证券-红岸工作室 · 12-18
健帆生物12月18日现1笔大宗交易 成交金额207.93万元
12月18日健帆生物现1笔折价20.49%的大宗交易 合计成交207.93万元
证券之星 · 12-18
12月18日健帆生物现1笔折价20.49%的大宗交易 合计成交207.93万元
健帆生物（300529）12月17日主力资金净卖出40.54万元
证券之星 · 12-18
健帆生物（300529）12月17日主力资金净卖出40.54万元
12月16日健帆生物现1笔折价19.35%的大宗交易 合计成交210.02万元
证券之星 · 12-16
12月16日健帆生物现1笔折价19.35%的大宗交易 合计成交210.02万元
健帆生物12月13日现1笔大宗交易 成交金额216.04万元
新浪证券-红岸工作室 · 12-13
健帆生物12月13日现1笔大宗交易 成交金额216.04万元
12月13日健帆生物现1笔折价18.63%的大宗交易 合计成交216.04万元
证券之星 · 12-13
12月13日健帆生物现1笔折价18.63%的大宗交易 合计成交216.04万元
健帆生物(300529.SZ)：血浆分离器获得欧盟MDR认证
智通财经 · 12-12
健帆生物(300529.SZ)：血浆分离器获得欧盟MDR认证
健帆生物最新公告：全资子公司产品获得欧盟MDR认证
证券之星 · 12-12
健帆生物最新公告：全资子公司产品获得欧盟MDR认证
健帆生物（300529）12月5日主力资金净买入106.82万元
证券之星 · 12-06
健帆生物（300529）12月5日主力资金净买入106.82万元
健帆生物：11月26日组织现场参观活动，珠海上市公司协会、嘉强基金等多家机构参与
证券之星 · 11-28
健帆生物：11月26日组织现场参观活动，珠海上市公司协会、嘉强基金等多家机构参与
健帆生物最新公告：聘任李峰为公司副总经理
证券之星 · 11-21
健帆生物最新公告：聘任李峰为公司副总经理
11月7日健帆生物涨6.06%，天弘中证500指数增强A基金重仓该股
证券之星 · 11-07
11月7日健帆生物涨6.06%，天弘中证500指数增强A基金重仓该股
健帆生物（300529）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 10-20
健帆生物（300529）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
健帆生物(300529)9月30日股东户数4.78万户，较上期减少2.57%
证券之星 · 10-18
健帆生物(300529)9月30日股东户数4.78万户，较上期减少2.57%
健帆生物最新公告：第三季度净利润同比增长63.62%
证券之星 · 10-18
健帆生物最新公告：第三季度净利润同比增长63.62%
健帆生物(300529.SZ)发布前三季度业绩，净利润7.92亿元，同比增长86.86%
智通财经网 · 10-18
健帆生物(300529.SZ)发布前三季度业绩，净利润7.92亿元，同比增长86.86%
健帆生物（300529）10月14日主力资金净买入1.39万元
证券之星 · 10-15
健帆生物（300529）10月14日主力资金净买入1.39万元
健帆生物（300529）10月11日主力资金净卖出6564.02万元
证券之星 · 10-14
健帆生物（300529）10月11日主力资金净卖出6564.02万元
10月9日健帆生物跌9.31%，天弘中证500指数增强A基金重仓该股
证券之星 · 10-09
10月9日健帆生物跌9.31%，天弘中证500指数增强A基金重仓该股
9月26日健帆生物涨6.95%，天弘中证500指数增强A基金重仓该股
证券之星 · 09-26
9月26日健帆生物涨6.95%，天弘中证500指数增强A基金重仓该股
暂无数据
公司概况
公司名称：
健帆生物科技集团股份有限公司
所属行业：
专用设备制造业
上市日期：
2016-08-02
主营业务：
健帆生物科技集团股份有限公司主要从事生物材料和高科技医疗器械的研发、生产及销售。主要产品有血液灌流器、血液净化设备、血液透析粉液产品。公司先后获评为国家火炬计划重点高新技术企业、国家制造业单项冠军示范企业、国家技术创新示范企业、国家知识产权示范企业。荣获国家科技进步二等奖、广东省科学技术进步一等奖。
发行价格：
10.80
{"stockData":{"symbol":"300529","market":"SZ","secType":"STK","nameCN":"健帆生物","latestPrice":29.97,"timestamp":1734678189000,"preClose":30.06,"halted":0,"volume":4051317,"delay":0,"floatShares":512000000,"shares":799000000,"eps":1.0074,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.09,"latestTime":"12-20 15:00:00","open":30,"high":30.6,"low":29.9,"amount":123000000,"amplitude":0.0233,"askPrice":29.97,"askSize":7,"bidPrice":29.93,"bidSize":10,"shortable":0,"etf":0,"ttmEps":1.0074,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":30.06,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":33.07,"lowLimit":27.05,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":798605275,"pbRate":7.57,"roa":"--","roe":"23.44%","epsLYR":0.55,"committee":0.140845,"marketValue":23934000000,"floatMarketCap":15359000000,"peRate":29.74985,"changeRate":-0.003,"turnoverRate":0.0079,"status":1},"requestUrl":"/m/hq/s/300529/tweets","defaultTab":"tweets","newsList":[{"id":"2492972760","title":"健帆生物12月18日现1笔大宗交易 成交金额207.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492972760","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492972760?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:00","pubTimestamp":1734512400,"startTime":"0","endTime":"0","summary":" 12月18日，健帆生物收涨0.67%，收盘价为30.06元，发生1笔大宗交易，合计成交量8.7万股，成交金额207.93万元。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为633.99万元。该股近5个交易日累计下跌0.89%，主力资金合计净流入197.69万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-18/doc-inczwpwp8044569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2492724209","title":"12月18日健帆生物现1笔折价20.49%的大宗交易 合计成交207.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492724209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492724209?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:57","pubTimestamp":1734512277,"startTime":"0","endTime":"0","summary":"证券之星消息，12月18日健帆生物发生大宗交易，交易数据如下：大宗交易成交价格23.9元，相对当日收盘价折价20.49%，成交8.7万股，成交金额207.93万元，买方营业部为平安证券股份有限公司郑州金水东路证券营业部，卖方营业部为平安证券股份有限公司晋江泉安中路证券营业部。近三个月该股共发生3笔大宗交易，合计成交2620.0手，折价成交3笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800028659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2492653946","title":"健帆生物（300529）12月17日主力资金净卖出40.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492653946","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492653946?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:21","pubTimestamp":1734484863,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月17日收盘，健帆生物报收于29.86元，下跌0.23%，换手率0.76%，成交量3.89万手，成交额1.16亿元。近5日资金流向一览见下表：健帆生物融资融券信息显示，融资方面，当日融资买入1186.28万元，融资偿还619.1万元，融资净买入567.17万元。健帆生物主营业务：生物材料和高科技医疗器械的研发、生产及销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800009761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2491543186","title":"12月16日健帆生物现1笔折价19.35%的大宗交易 合计成交210.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491543186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491543186?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:48","pubTimestamp":1734338887,"startTime":"0","endTime":"0","summary":"证券之星消息，12月16日健帆生物发生大宗交易，交易数据如下：大宗交易成交价格24.14元，相对当日收盘价折价19.35%，成交8.7万股，成交金额210.02万元，买方营业部为平安证券股份有限公司郑州金水东路证券营业部，卖方营业部为平安证券股份有限公司晋江泉安中路证券营业部。近三个月该股共发生2笔大宗交易，合计成交1750.0手，折价成交2笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600021287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2491490913","title":"健帆生物12月13日现1笔大宗交易 成交金额216.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491490913","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491490913?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:01","pubTimestamp":1734080460,"startTime":"0","endTime":"0","summary":" 12月13日，健帆生物收跌1.66%，收盘价为30.17元，发生1笔大宗交易，合计成交量8.8万股，成交金额216.04万元。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为216.04万元。该股近5个交易日累计下跌0.69%，主力资金合计净流出194.54万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-13/doc-incziefr2753604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2491463313","title":"12月13日健帆生物现1笔折价18.63%的大宗交易 合计成交216.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491463313","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491463313?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:49","pubTimestamp":1734079780,"startTime":"0","endTime":"0","summary":"证券之星消息，12月13日健帆生物发生大宗交易，交易数据如下：大宗交易成交价格24.55元，相对当日收盘价折价18.63%，成交8.8万股，成交金额216.04万元，买方营业部为平安证券股份有限公司郑州金水东路证券营业部，卖方营业部为平安证券股份有限公司晋江泉安中路证券营业部。近三个月该股共发生1笔大宗交易，合计成交880.0手，折价成交1笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300028965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2490880601","title":"健帆生物(300529.SZ)：血浆分离器获得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2490880601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490880601?lang=zh_cn&edition=full","pubTime":"2024-12-12 19:11","pubTimestamp":1734001895,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健帆生物(300529.SZ)公告，公司全资子公司珠海健帆血液净化科技有限公司(简称“健帆血液净化公司”)于近日收到欧盟公告机构通知，其产品血浆分离器获得按照欧盟医疗器械法规Medical Devices Regulation（EU）2017/745(简称“MDR”)签发的欧盟MDR认证，可在欧盟国家及其他认可欧盟CE认证国家销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"健帆生物(300529.SZ)：血浆分离器获得欧盟MDR认证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2490480349","title":"健帆生物最新公告：全资子公司产品获得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2490480349","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490480349?lang=zh_cn&edition=full","pubTime":"2024-12-12 18:31","pubTimestamp":1733999465,"startTime":"0","endTime":"0","summary":"健帆生物公告，全资子公司健帆血液净化公司于近日收到欧盟公告机构通知，其产品血浆分离器获得按照欧盟医疗器械法规Medical Devices Regulation（EU）2017/745（MDR）签发的欧盟MDR认证，可在欧盟国家及其他认可欧盟CE认证国家销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200030952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2489442012","title":"健帆生物（300529）12月5日主力资金净买入106.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489442012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489442012?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:23","pubTimestamp":1733448186,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月5日收盘，健帆生物报收于29.55元，下跌1.04%，换手率1.13%，成交量5.77万手，成交额1.71亿元。近5日资金流向一览见下表：健帆生物融资融券信息显示，融资方面，当日融资买入1310.44万元，融资偿还7529.44万元，融资净偿还6219.01万元。健帆生物主营业务：生物材料和高科技医疗器械的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600008964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2486706362","title":"健帆生物：11月26日组织现场参观活动，珠海上市公司协会、嘉强基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2486706362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486706362?lang=zh_cn&edition=full","pubTime":"2024-11-28 16:44","pubTimestamp":1732783468,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月28日健帆生物发布公告称公司于2024年11月26日组织现场参观活动，珠海上市公司协会、嘉强基金、疆亘投资、鼎华投资、企悦投资、谢诺投资、熙宁投资、聚亿基金、华泰证券、广州私募基金协会、汇聚投资、玄甲基金、宸泽基金、太朴持信、附加值投资、广东岭信控股参与。综上，公司在今年前三季度实现了 81.31%的高毛利率水平，公司有信心将毛利率维持在较高水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800025836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2485459472","title":"健帆生物最新公告：聘任李峰为公司副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2485459472","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485459472?lang=zh_cn&edition=full","pubTime":"2024-11-21 16:38","pubTimestamp":1732178308,"startTime":"0","endTime":"0","summary":"健帆生物公告，公司于2024年11月21日召开第五届董事会第二十三次会议，审议通过《关于聘任副总经理的议案》。同意聘任李峰为公司副总经理，任期自本次董事会审议通过之日起至公司第五届董事会届满之日止。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100025596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2481298019","title":"11月7日健帆生物涨6.06%，天弘中证500指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481298019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481298019?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:21","pubTimestamp":1730967687,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日健帆生物涨6.06%，收盘报33.78元，换手率2.66%，成交量13.65万手，成交额4.48亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为天弘中证500指数增强A。天弘中证500指数增强A目前规模为23.48亿元，最新净值1.2298，较上一交易日上涨0.26%，近一年上涨12.73%。天弘中证500指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399905","000001.SH","000905.SH","BK0251","300529","159982"],"gpt_icon":0},{"id":"2476574574","title":"健帆生物（300529）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2476574574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476574574?lang=zh_cn&edition=full","pubTime":"2024-10-20 06:02","pubTimestamp":1729375356,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期健帆生物发布2024年三季报。截至本报告期末，公司营业总收入21.96亿元，同比上升47.76%，归母净利润7.92亿元，同比上升86.86%。本报告期健帆生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达38.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000000194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529"],"gpt_icon":0},{"id":"2476405015","title":"健帆生物(300529)9月30日股东户数4.78万户，较上期减少2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476405015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476405015?lang=zh_cn&edition=full","pubTime":"2024-10-18 17:09","pubTimestamp":1729242542,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健帆生物披露，截至2024年9月30日公司股东户数为4.78万户，较6月30日减少1259.0户，减幅为2.57%。在医疗器械行业个股中，健帆生物股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.0万户。从股价来看，2024年6月30日至2024年9月30日，健帆生物区间涨幅为20.32%，在此期间股东户数减少1259.0户，减幅为2.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800027864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529","BK0251"],"gpt_icon":0},{"id":"2476405360","title":"健帆生物最新公告：第三季度净利润同比增长63.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476405360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476405360?lang=zh_cn&edition=full","pubTime":"2024-10-18 17:02","pubTimestamp":1729242171,"startTime":"0","endTime":"0","summary":"健帆生物发布2024年第三季度报告，报告期内，公司实现营业收入7.00亿元，同比增长47.74%；归属于上市公司股东的净利润为2.39亿元，同比增长63.62%；归属于上市公司股东的扣除非经常性损益的净利润为2.28亿元，同比增长61.34%。基本每股收益为0.3元，同比增长66.67%。加权平均净资产收益率为7.56%，同比增加3.15个百分点。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800027505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300529"],"gpt_icon":0},{"id":"2476470865","title":"健帆生物(300529.SZ)发布前三季度业绩，净利润7.92亿元，同比增长86.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476470865","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476470865?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:33","pubTimestamp":1729240405,"startTime":"0","endTime":"0","summary":"健帆生物(300529.SZ)发布2024年第三季度报告，公司前三季度营业收入21...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300529"],"gpt_icon":0},{"id":"2475832091","title":"健帆生物（300529）10月14日主力资金净买入1.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475832091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475832091?lang=zh_cn&edition=full","pubTime":"2024-10-15 09:26","pubTimestamp":1728955583,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月14日收盘，健帆生物报收于31.18元，上涨0.29%，换手率2.1%，成交量10.74万手，成交额3.31亿元。近5日资金流向一览见下表：健帆生物融资融券信息显示，融资方面，当日融资买入2582.24万元，融资偿还2243.79万元，融资净买入338.45万元，连续3日净买入累计1370.87万元。健帆生物主营业务：生物材料和高科技医疗器械的研发、生产及销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500007809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2475524803","title":"健帆生物（300529）10月11日主力资金净卖出6564.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475524803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475524803?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:23","pubTimestamp":1728868994,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月11日收盘，健帆生物报收于31.09元，下跌7.44%，换手率2.74%，成交量14.02万手，成交额4.43亿元。近5日资金流向一览见下表：健帆生物融资融券信息显示，融资方面，当日融资买入3759.52万元，融资偿还3594.7万元，融资净买入164.82万元。健帆生物主营业务：生物材料和高科技医疗器械的研发、生产及销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400002632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300529"],"gpt_icon":0},{"id":"2474211807","title":"10月9日健帆生物跌9.31%，天弘中证500指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474211807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474211807?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:34","pubTimestamp":1728466488,"startTime":"0","endTime":"0","summary":"证券之星消息，10月9日健帆生物跌9.31%，收盘报34.3元，换手率4.14%，成交量21.21万手，成交额7.58亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为天弘中证500指数增强A。天弘中证500指数增强A目前规模为21.06亿元，最新净值1.2417，较上一交易日上涨6.68%，近一年上涨11.12%。天弘中证500指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900031673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000905.SH","300529","159982","399905","000001.SH","BK0251"],"gpt_icon":0},{"id":"2470202818","title":"9月26日健帆生物涨6.95%，天弘中证500指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470202818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470202818?lang=zh_cn&edition=full","pubTime":"2024-09-26 16:52","pubTimestamp":1727340741,"startTime":"0","endTime":"0","summary":"证券之星消息，9月26日健帆生物涨6.95%，收盘报26.79元，换手率1.53%，成交量7.86万手，成交额2.04亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为天弘中证500指数增强A。天弘中证500指数增强A目前规模为21.06亿元，最新净值0.9733，较上一交易日上涨0.7%，近一年下跌12.54%。天弘中证500指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600024150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000905.SH","000001.SH","159982","BK0251","399905","300529"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-08-02","address":"广东省珠海市香洲区高新区科技六路98号","stockEarnings":[{"period":"1week","weight":-0.0066},{"period":"1month","weight":-0.0489},{"period":"3month","weight":0.2323},{"period":"6month","weight":0.0918},{"period":"1year","weight":0.3833},{"period":"ytd","weight":0.3677}],"companyName":"健帆生物科技集团股份有限公司","boardCode":"AI0035","perCapita":"10717股","boardName":"专用设备制造业","registeredCapital":"79860万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 健帆生物科技集团股份有限公司主要从事生物材料和高科技医疗器械的研发、生产及销售。主要产品有血液灌流器、血液净化设备、血液透析粉液产品。公司先后获评为国家火炬计划重点高新技术企业、国家制造业单项冠军示范企业、国家技术创新示范企业、国家知识产权示范企业。荣获国家科技进步二等奖、广东省科学技术进步一等奖。","serverTime":1734857704880,"listedPrice":10.8,"stockholders":"47817人(较上一季度减少2.57%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健帆生物(300529)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健帆生物(300529)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健帆生物,300529,健帆生物股票,健帆生物股票老虎,健帆生物股票老虎国际,健帆生物行情,健帆生物股票行情,健帆生物股价,健帆生物股市,健帆生物股票价格,健帆生物股票交易,健帆生物股票购买,健帆生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健帆生物(300529)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健帆生物(300529)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}